Juan Pablo Terreros-Dorado

Juan Pablo Terreros-Dorado

Auto-generated profile, based on publicly available information

Juan Pablo Terreros-Dorado

Neuroscience Research Group “NeURos”, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
WRWilliam Rojas-Carabali
William Rojas-Carabali
PUPilar Uribe-Reina
Pilar Uribe-Reina
JMJuliana Muñoz-Ortiz
Juliana Muñoz-Ortiz
JTJuan Pablo Terreros-Dorado
Juan Pablo Terreros-Dorado
MRMaría Eugenia Ruiz-Botero
María Eugenia Ruiz-Botero
ADAlejandra de-la-Torre
Alejandra de-la-Torre
Purpose: To describe ocular surface characteristics and tests’ results in a healthy pediatric population. Methods: We performed a cross-sectional study with 60 healthy children, obtaining consent, OSDI and screen use survey and conducting ocular surface tests. Statistical univariate analysis for categorical and quantitative variables was made. To describe the correlation of the results in both eyes, we used a model of random effects. To characterize the possible profiles of device use, we applied the mixed-cluster methodology. Results: Sixty healthy children between 7 and 17 years old were evaluated. Girl’s proportion was 41.6%. Mean Ocular Surface Disease Index Score was 9.98± 8.49 points. Daily screen time was 5.59± 2.77 hours and the most popular screen was the smartphone. Mean results (with standard deviations or confidence intervals) of ocular surface tests were blink frequency while reading on paper, 6.8± 5.68 times per minute; blink frequency while reading on screen, 8.7± 7.14 times per minute; tear meniscus height, 0.19[0.18– 0.2] mm; non-invasive tear break-up time, 12.44[10.99– 13.9] seconds; nasal conjunctival redness, 0.86[0.77– 0.94]; temporal conjunctival redness, 0.96[0.87– 1.04]; tear osmolarity, 299.3[295.14– 303.45] mmol; and Schirmer test, 23.73[21.28– 26.18] mm. Lid margin was irregular in three eyes; 44.7% had thin lipid layer; lissamine green staining was positive in 70.8%; fluorescein staining was positive in 47.4%; 36.64% exhibited partial meibomian gland loss. Conclusion: Considering the scarcity of specific pediatric values of ocular surface tests, we performed a clinical investigation involving the complete pool of ocular surface tests in children. Although healthy children were included in this study, we found that all the participants had at least one abnormal result and 33.33% had dry eye disease diagnosis, according to the TFOS DEWS II. It would be relevant to carry out further multicentric studies to compare our ocular surface tests’ results with other groups of children.

1 June 2021 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
PUPilar Uribe-Reina
Pilar Uribe-Reina
JMJuliana Muñoz-Ortiz
Juliana Muñoz-Ortiz
CGCarlos Humberto Cifuentes González
Carlos Humberto Cifuentes González
JRJuliana Reyes-Guanes
Juliana Reyes-Guanes
JTJuan Pablo Terreros-Dorado
Juan Pablo Terreros-Dorado
ADAlejandra de-la-Torre
Alejandra de-la-Torre
Purpose: To establish the prevalence of ocular involvement in a Colombian population with rheumatologic diseases. Design: Observational cross-sectional study. Methods: We included a probabilistic sample size of 797 patients who attended a rheumatologic disease center in Bogotá, Colombia. Statistical analysis with descriptive measures and Chi-square independence test between rheumatologic diseases and ophthalmological symptoms and diseases was performed. Results: Eighty-four percent of the population were women, and the mean age was 54.61± 15.64 years. The most common condition was rheumatoid arthritis (33.37%), followed by fibromyalgia (22.71%), Sjögren Syndrome (19.72%), and systemic lupus erythematosus (9.91%). Almost 7% of the patients presented polyautoimmunity. Thirty-five percent of the patients reported one or more ophthalmological symptoms, being dry eye sensation the most common (30.86%), followed by ocular pain (2.76%), red-eye, and decreased visual acuity (both 2.63%). Similarly, 21.45% of the patients presented one or more ophthalmological diagnoses, being keratoconjunctivitis sicca the most common (15.93%), followed by cataract, uveitis (1.38% each), and scleritis (1.25%). Conclusion: Almost a third of the patients reported any ocular involvement. It is crucial to be aware of the most common ophthalmic manifestations among the different rheumatologic diseases in our population, to offer early specialist referral and timely treatment.